ATE556722T1 - Herstellung von vierzähnigen peptidchelatkonjugaten zur diagnose von kolorektalem krebs - Google Patents

Herstellung von vierzähnigen peptidchelatkonjugaten zur diagnose von kolorektalem krebs

Info

Publication number
ATE556722T1
ATE556722T1 AT02701431T AT02701431T ATE556722T1 AT E556722 T1 ATE556722 T1 AT E556722T1 AT 02701431 T AT02701431 T AT 02701431T AT 02701431 T AT02701431 T AT 02701431T AT E556722 T1 ATE556722 T1 AT E556722T1
Authority
AT
Austria
Prior art keywords
preparation
colorectal cancer
conjugates
dental
diagnosing colorectal
Prior art date
Application number
AT02701431T
Other languages
German (de)
English (en)
Inventor
Alan Cuthbertson
Marivi Mendizabal
Mark Dixon
Anthony Storey
Edward Bacon
Vinay Desai
Sudakar Kasina
Henry Wolfe
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Application granted granted Critical
Publication of ATE556722T1 publication Critical patent/ATE556722T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Optics & Photonics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT02701431T 2001-03-02 2002-03-01 Herstellung von vierzähnigen peptidchelatkonjugaten zur diagnose von kolorektalem krebs ATE556722T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0105224.0A GB0105224D0 (en) 2001-03-02 2001-03-02 Improved peptide-chelate conjugates
PCT/GB2002/000857 WO2002070018A2 (en) 2001-03-02 2002-03-01 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis

Publications (1)

Publication Number Publication Date
ATE556722T1 true ATE556722T1 (de) 2012-05-15

Family

ID=9909880

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02701431T ATE556722T1 (de) 2001-03-02 2002-03-01 Herstellung von vierzähnigen peptidchelatkonjugaten zur diagnose von kolorektalem krebs

Country Status (8)

Country Link
US (1) US7608242B2 (enExample)
EP (1) EP1368064B1 (enExample)
JP (1) JP2004524323A (enExample)
AT (1) ATE556722T1 (enExample)
CA (1) CA2439579A1 (enExample)
ES (1) ES2385028T3 (enExample)
GB (1) GB0105224D0 (enExample)
WO (1) WO2002070018A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0224799D0 (en) * 2002-10-25 2002-12-04 Amersham Plc Improved complex compositions
NO20030115D0 (no) 2003-01-09 2003-01-09 Amersham Health As Kontrastmiddel
EP1599165A4 (en) * 2003-02-10 2010-09-08 Univ Jefferson THE USE OF GCC LIGANDS
US7842280B2 (en) * 2006-09-06 2010-11-30 Case Western Reserve University Flexibly labeling peptides
WO2009108868A2 (en) * 2008-02-27 2009-09-03 Radiomedix Inc. Radiolabeled hedgehog derivatives for imaging and therapy
WO2010027473A2 (en) * 2008-09-03 2010-03-11 Board Of Trustees Of Michigan State University Immunogenic escherichia coli heat stable enterotoxin
CN102822194B (zh) * 2009-12-07 2016-10-26 硬木药品公司 用于胃肠病症的治疗
GB201016206D0 (en) * 2010-09-27 2010-11-10 Ge Healthcare Ltd Apoptosis imaging agents
GB201103696D0 (en) 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
US9617305B2 (en) 2011-06-08 2017-04-11 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
WO2012170766A1 (en) 2011-06-08 2012-12-13 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
WO2015084996A1 (en) * 2013-12-03 2015-06-11 Millennium Pharmaceuticals, Inc. Compounds and compositions for imaging gcc-expressing cells
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545931A (en) 1983-01-03 1985-10-08 Scripps Clinic And Research Foundation Synthetic heat-stable enterotoxin polypeptide of Escherichia coli
US4886663A (en) 1983-01-03 1989-12-12 Scripps Clinic And Research Foundation Synthetic heat-stable enterotoxin polypeptide of Escherichia coli and multimers thereof
US5242679A (en) * 1985-01-14 1993-09-07 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5849261A (en) 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
WO1994008949A2 (en) * 1992-10-08 1994-04-28 Amersham International Plc Metal-oxime chelates for use as radiopharmaceutical agents
CA2167281C (en) 1993-07-15 2001-09-04 Richard T. Dean Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
AU7261994A (en) * 1993-07-19 1995-02-20 Resolution Pharmaceuticals Inc. Hydrazino-type radionuclide chelators having an n3s configuration
JP4194113B2 (ja) 1993-10-26 2008-12-10 トーマス・ジェファーソン・ユニバーシティ 結腸直腸癌細胞に特異的に結合する組成物およびその使用方法
US5518888A (en) 1993-10-26 1996-05-21 Thomas Jefferson University ST receptor binding compounds and methods of using the same
DE19536781A1 (de) 1995-09-21 1997-03-27 Diagnostikforschung Inst Bifunktionelle sulfidhaltige Sulfonamid-Chelatbildner vom Typ XSNS für radioaktive Isotope
AU9452198A (en) * 1997-10-15 1999-05-17 Nycomed Imaging As Complexing agents and targeting immunoreagents
WO1999039748A1 (en) 1998-02-06 1999-08-12 Nycomed Imaging As Targeting immunoreagents useful in therapeutic and diagnostic compositions and methods

Also Published As

Publication number Publication date
US20060222593A1 (en) 2006-10-05
GB0105224D0 (en) 2001-04-18
WO2002070018A3 (en) 2002-12-05
ES2385028T3 (es) 2012-07-17
CA2439579A1 (en) 2002-09-12
US7608242B2 (en) 2009-10-27
EP1368064A2 (en) 2003-12-10
EP1368064B1 (en) 2012-05-09
WO2002070018A2 (en) 2002-09-12
JP2004524323A (ja) 2004-08-12

Similar Documents

Publication Publication Date Title
ATE556722T1 (de) Herstellung von vierzähnigen peptidchelatkonjugaten zur diagnose von kolorektalem krebs
ATE487498T1 (de) Verbesserte radiometall-komplex-zusammensetzungen
DK1404377T3 (da) Forbedrede chelatorkonjugater
ATE340594T1 (de) Somatostatin bindende peptide-metallchelat konjugate
DK1092155T3 (da) Fremgangsmåde til tidlig diagnose af carcinomer
WO2001073030A3 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer
WO2006107794A3 (en) Poly(peptide) as a chelator: methods of manufacture and uses
ATE298757T1 (de) Ternärligand-komplexe verwendbar als radiopharmazeutika
IL175667A (en) Imaging factor that includes a synthetic caspase-3 inhibitor marked with the neuroimaging agent, a radiopharmaceutical containing it, a kit for preparation of the preparation and a method for diagnosis based on it
WO2001075169A3 (en) Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer
ATE234639T1 (de) Technetium-99m markierte bildformungsmittel
JP2004524323A5 (enExample)
BR0315578A (pt) Composição de complexo de tecnécio, produto radiofarmacêutico, kit para a preparação do produto radiofarmacêutico de tecnécio, e, método de formação de imagem de diagnóstico de trombos
WO2002040060A3 (en) Conjugates of an antioxidants with metal chelating ligands
DE69723242D1 (de) Ternäre radiopharmazeutische komplexe
AU3602695A (en) Novel n3s2 chelating ligands optionally radiolabelled with tc or re, useful for diagnostic or therapeutic applications
WO2001080906A3 (en) Radiometal complexes of 2-pyrrolylthiones for imaging a therapy
WO2002066075A3 (en) Biotin-derivatives and their conjugates with chelating agents
ATE537849T1 (de) Neue technetium- und rhenium-komplexe, bei ihrer herstellung verwendete liganden und ihre verwendung als radiopharmazeutika
EP1730160A4 (en) Neoplasia diagnostic compositions and methods of use
WO2006003330A3 (fr) Collections de composes tracables et leurs utilisations
WO2000009076A8 (en) Imaging with tc-99m labeled fibrin-alpha-chain peptide
Kulatunga Evaluation of samarium-153-BCPDA conjugates for applications in radioimmunotherapy.
WO2002018944A3 (de) Mittel zur diagnose von tumoren